Delivery Order SPE2DB22D3301-SPE2DB24FX7HN
Award Date 12/19/23
Potential Completion Date 12/20/23
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $12,464.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 0.5 mg/ml oral suspension (340 ml) on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026. The performance location...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,231.73 contract is for the supply of FYCOMPA 6 MG TABLET 30S, a prescription medication, with a completion date of February 28, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the supply of FYCOMPA 2 MG TABLET 30S, a specialty pharmaceutical product, with a potential value of $3,189.15 and a completion date of February 12, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and...
- The Defense Logistics Agency awarded a $2,067.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 MG tablets (30-count packaging) on July 10, 2025, with completion expected by July 11, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FYCOMPA 0.5 mg/ml oral suspension in 340 ml quantities, with a ceiling value of $3,194.49. It is a firm fixed-price contract with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of FYCOMPA 4 MG TABLET 30S, a pharmaceutical product, with a potential value of $4,141.68 and a completion date of January 8, 2024. Amerisourcebergen Drug Corp, as the prime contractor, has a history of providing pharmaceutical products and medical supplies to...
- This federal contract award, valued at $3,848.96, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the corporate office of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a prescription medication, to the DLA. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen holds a larger...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,786.49 firm fixed-price delivery order is for the supply of FYCOMPA 0.5 MG/ML oral suspension, a prescription medication, with a completion date of June 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds significant...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of FYCOMPA 12 mg tablets (30-count) with a contract value of $1,051.80. The award is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 14, 2025, valued at $1,489.87 for the supply of Fycompa 2 mg tablets (30-count packages) under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order issued by the Defense Logistics Agency's Medical Supply Chain, a component of the Department of Defense. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of...